Baxter International Officer Steven P. Wallace Tax Withholding Stock Transaction

This Form 4 filing reports a transaction by Steven P. Wallace, President of Advanced Surgery at Baxter International Inc. On June 2, 2026, Wallace forfeited 153 shares of Baxter common stock at a price of $18.68 per share to cover tax withholding obligations resulting from the settlement of vested restricted stock units. The restricted stock units were originally granted on June 2, 2025. Following this transaction, Wallace's ownership position in Baxter International decreased to 70,128 shares. The filing represents a routine tax withholding transaction rather than a discretionary sale, as the shares were automatically forfeited to cover tax liabilities associated with equity compensation vesting. This type of transaction is common for executives receiving equity-based compensation.